While our data supports PBD as a safe payload for the ALK binder CDX0239 when conjugated to a chemically stable linker, payload diversification with alternate mechanisms of action tailored to tumor sensitivities, such as topoisomerase inhibitors is crucial41. The gene discussed is ALK; the disease is neoplasm.